6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  NeuroReport

• Publication date

  1994-01-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00001756-199401120-00014PMID 8003668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nerve growth factor revisited.

  1993cited by this paper
• Coexpression of neurotrophins and their receptors in neurons of the central nervous system.

  1993cited by this paper
• Neuronal colocalization of mRNAs for neurotrophins and their receptors in the developing central nervous system suggests a potential for autocrine interactions.

  1993cited by this paper
• Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death

  1992cited by this paper
• Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section

  1992cited by this paper
• Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain

  1992cited by this paper
• Function and evolution in the NGF family and its receptors

  1992cited by this paper
• p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF.

  1992cited by this paper
• Neurotrophin receptors: a window into neuronal differentiation.

  1992cited by this paper
• Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons.

  1992cited by this paper
• Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

  1991cited by this paper
• Messenger RNAs for trk and the low-affinity NGF receptor in rat basal forebrain.

  1991cited by this paper
• BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

  1991cited by this paper
• Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain.

  1990cited by this paper
• Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons.

  1990cited by this paper
• Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization.

  1990cited by this paper
• Neurotrophin-3: a neurotrophic factor related to NGF and BDNF.

  1990cited by this paper
• Molecular cloning and expression of brain-derived neurotrophic factor

  1989cited by this paper
• Combined in situ hybridization and immunocytochemistry in the assay of pharmacological effects on tyrosine hydroxylase mRNA concentration.

  1989cited by this paper
• Brain-derived neurotrophic factor prevents neuronal death in vivo

  1988cited by this paper
• In vivo effect of brain‐derived neurotrophic factor on the survival of developing dorsal root ganglion cells.

  1987cited by this paper
• Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons.

  1986cited by this paper
• Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation.

  1985cited by this paper
• [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.

  1984cited by this paper

• BDNF-Regulated Modulation of Striatal Circuits and Implications for Parkinson’s Disease and Dystonia

  2024cites this paper
• CONSEQUENCES OF DOPAMINERGIC AGONIST ASSOCIATED WITH BDNF TREATMENT ON BEHAVIORAL ALTERATIONS AND CYTOLOGICAL CHANGES IN AN EXPERIMENTAL MODEL OF PARKINSON DISEASE DUE TO MANGANESE EXPOSURE.

  2018cites this paper
• Exposure to an enriched environment facilitates motor recovery and prevents short‐term memory impairment and reduction of striatal BDNF in a progressive pharmacological model of parkinsonism in mice

  2017cites this paper
• Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity.

  2015cites this paper
• Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats

  2015cites this paper
• The Transfection of BDNF to Dopamine Neurons Potentiates the Effect of Dopamine D3 Receptor Agonist Recovering the Striatal Innervation, Dendritic Spines and Motor Behavior in an Aged Rat Model of Parkinson’s Disease

  2015cites this paper
• Neurotrophic support of midbrain dopaminergic neurons.

  2009cites this paper
• Role of brain-derived neurotrophic factor in Huntington's disease.

  2007cites this paper
• Developmental expression of neurotrophins and their receptors in postnatal rat ventral midbrain

  2007cites this paper
• Neurotrophin receptor heterozygosity causes deficits in catecholaminergic innervation of amygdala and hippocampus in aged mice

  2006cites this paper
• Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.

  2005cites this paper
• Toxin-induced models of Parkinson’s disease

  2005cites this paper
• Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of α‐synuclein in the substantia nigra

  2005cites this paper
• Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice.

  2004cites this paper
• Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.

  2004cites this paper
• Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra.

  2002cites this paper
• Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion.

  2001cites this paper
• Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

  2001cites this paper
• Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway.

  2000cites this paper
• Upregulation of BDNF mRNA and trkB mRNA in the nigrostriatal system and in the lesion site following unilateral transection of the medial forebrain bundle.

  2000cites this paper
• Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain.

  2000cites this paper
• Evidence that Brain-Derived Neurotrophic Factor from Presynaptic Nerve Terminals Regulates the Phenotype of Calbindin-Containing Neurons in the Lateral Septum

  2000cites this paper
• Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release.

  2000cites this paper
• Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: A double‐label in situ hybridization study

  1999cites this paper
• Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets

  1999cites this paper
• Serotonin hyperinnervation in the adult rat ventral mesencephalon following unilateral transection of the medial forebrain bundle. Correlation with reactive microglial and astroglial populations.

  1999cites this paper
• The Use of Neurotoxins to Lesion Catecholamine-Containing Neurons to Model Clinical Disorders

  1998cites this paper
• Increased Expression of trkB mRNA in Rat Caudate‐Putamen Following 6–OHDA Lesions of the Nigrostriatal Pathway

  1997cites this paper
• Expression of brain-derived neurotrophic factor and TrkB neurotrophin receptors after striatal injury in the mouse.

  1997cites this paper
• Immunocytochemical localization of TrkB in the central nervous system of the adult rat

  1997cites this paper
• The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain.

  1996cites this paper
• The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.

  1996cites this paper
• Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae.

  1996cites this paper
• Development of striatal dopaminergic function. III: Pre- and postnatal development of striatal and cortical mRNAs for the neurotrophin receptors trkBTK+ and trkC and their regulation by synaptic dopamine.

  1996cites this paper
• Enhanced synthesis of platelet-derived growth factor following injury induced by 6-hydroxydopamine in rat brain.

  1996cites this paper
• Prolonged expression of Fos-related antigens, Jun B and TrkB in dopamine-denervated striatal neurons.

  1995cites this paper
• Award Number DAMD 17-011-0766 TITLE : Neurotrophic Response to CNS Degeneration of Injury : Effects of Aging PRINCIPAL INVESTIGATOR :

  year unknowncites this paper